Increased production of reactive oxygen species of systemic PMN from COPD patients in comparison to healthy controls

A. Strassburg, I. Muenckel, K. Dalhoff (Luebeck, Germany)

Source: Annual Congress 2010 - Novel mechanisms in COPD
Session: Novel mechanisms in COPD
Session type: Thematic Poster Session
Number: 4341
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Strassburg, I. Muenckel, K. Dalhoff (Luebeck, Germany). Increased production of reactive oxygen species of systemic PMN from COPD patients in comparison to healthy controls. Eur Respir J 2010; 36: Suppl. 54, 4341

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled H2O2 correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002

Analysis of reactive oxygen species in sputum neutrophils during acute exacerbation of COPD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012

Role of complex I and III in the production of reactive oxygen species by mitochondria of peripheral muscle in COPD subjects
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009

Altered reactive oxygen species generation in neutrophils of children with pollinosis
Source: Eur Respir J 2005; 26: Suppl. 49, 589s
Year: 2005

The influence of hydrogen peroxide on reactive oxygen species generation in monocytes of healthy children and with pollinosis
Source: Eur Respir J 2006; 28: Suppl. 50, 228s
Year: 2006

ROS production in PMN is higher during inflammation in NSCLC than in COPD
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Inhibition of reactive nitrogen species production in COPD airways: comparison between steroid and theophylline
Source: Eur Respir J 2005; 26: Suppl. 49, 293s
Year: 2005

Apocynin reduces reactive oxygen species generation in airways of asthmatics
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010

The role of reactive oxygen species in pulmonary inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 531s
Year: 2003

Elevated mitochondrial reactive oxygen species in COPD macrophages at exacerbation
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015

Active oxigen species generation by leukocytes in infants with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Influence of AECOPD to ROS production in neutrophils
Source: Annual Congress 2011 - COPD: human studies
Year: 2011

Altered mitochondrial reactive oxygen species (ROS) production in airway smooth muscle cells of severe asthma.
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019

Reactive oxygen and nitrogen species (ROS & RNS) are associated with respiratory muscle dysfunction in severe COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 120s
Year: 2004

Cytokines and reactive oxygen species (ROS) produced by alveolar macrophages (AM) in sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 68s
Year: 2001

Relationships between inflammatory markers, reactive oxygen species and body mass index in stable COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 161s
Year: 2006

Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Source: Eur Respir J 2004; 23: 496
Year: 2004


Effect of oxygen at low flows on concentration of exhaled 8-isoprostane in healthy and COPD subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 94s
Year: 2002

Reactive oxygen species concentrations are decreased by nebulized apocynin in exhaled breath condensate of healthy subjects
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Aminoguanidine inhibits bronchial NO production, but not diffusion or alveolar NO in patients with asthma, smokers and healthy volunteers
Source: Eur Respir J 2004; 24: Suppl. 48, 577s
Year: 2004